ShapeNine

Curated by Signal

Developer of AI-led platform for drug development

Overview

ShapeNine offers a platform for designing drug development. The software uses deep learning and AI technology to develop design DNA structures in the field of computational design, shape optimisation, DNA nanotechnology, and chemical engineering.

Key facts

Founded: 2019
Headquarters: London, United Kingdom
Stage: Sign up to view
Industry: Health Technology

Contact

Primary office: Sign up to view
Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Curamicus
Provider of assistive technology solutions for elderly care
Health TechnologyPoole, United Kingdom
Spoonful of Sugar
Provider of digital therapeutic services for healthcare providers
Health TechnologyHove, United Kingdom
Pamtrad
Manufacturer and retailer of magnifiers for partially blinded people
Health TechnologyWilford, United Kingdom

About ShapeNine

What does ShapeNine do?

ShapeNine offers a platform for designing drug development.

Where is ShapeNine headquartered?

ShapeNine is headquartered in London, United Kingdom.

When was ShapeNine founded?

ShapeNine was founded in 2019.

Which sector is ShapeNine in?

ShapeNine operates in Health Technology.

Who are ShapeNine's competitors?

Companies similar to ShapeNine include Curamicus, Spoonful of Sugar, and Pamtrad.